Ecotoxicological evaluation of propranolol hydrochloride and losartan potassium to Lemna minor L. (1753) individually and in binary mixtures

Ecotoxicology

Volumn 24, Issue 5, 2015, Pages 1112-1123

  Godoy, Aline A ^a   Kummrow, Fábio ^b   Pamplin, Paulo Augusto Z ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antihypertensive pharmaceuticals; Lemna minor; Mixture toxicity; Phytotoxicity; Water quality criteria

Indexed keywords

FRESH WATER; LOSARTAN POTASSIUM; PROPRANOLOL; SALT WATER; UNCLASSIFIED DRUG; WATER; ANTIHYPERTENSIVE AGENT; LOSARTAN; WATER POLLUTANT;

BIOACCUMULATION; DETECTION METHOD; DRUG; ECOTOXICOLOGY; ENVIRONMENTAL RISK; GROWTH RESPONSE; INHIBITION; PHYTOTOXICITY; WATER QUALITY;

ARTICLE; BINARY MIXTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MIXTURE; EC50; ECOTOXICOLOGY; GROWTH INHIBITION; LEMNA MINOR; MEASURED ENVIRONMENTAL CONCENTRATION; NONHUMAN; PH; PHYSICAL PARAMETERS; PREDICTED NO EFFECT CONCENTRATION; PRIORITY JOURNAL; PROTECTION; RISK FACTOR; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; WATER PROTECTION; WATER QUALITY; WATER QUALITY CRITERIA; ARACEAE; DRUG EFFECTS; ENVIRONMENTAL MONITORING; PROCEDURES; RISK ASSESSMENT; TOXICITY; WATER POLLUTANT;

LEMNA MINOR;

ANTIHYPERTENSIVE AGENTS; ARACEAE; ECOTOXICOLOGY; ENVIRONMENTAL MONITORING; LOSARTAN; PROPRANOLOL; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL; WATER QUALITY;

EID: 84930570906     PISSN: 09639292     EISSN: 15733017     Source Type: Journal    
DOI: 10.1007/s10646-015-1455-3     Document Type: Article

References (60)

1. Acuña V, von Schiller D, García-Galán MJ, Rodríguez-Mozaz S, Corominas L, Petrovic M, Poch M, Barceló D, Sabater S (2015) Occurrence and in-stream attenuation of wastewater-derived pharmaceuticals in Iberian rivers. Sci Total Environ 503–504:133–141. doi:10.1016/j.scitotenv.2014.05.067
2. Andreozzi R, Raffaele M, Nicklas P (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50:1319–1330. doi:10.1016/S0045-6535(02)00769-5
3. Berenbaum MC (1985) The expected effect of a combination of agents: the general solution. J Theor Biol 114:413–431. doi:10.1016/S0022-5193(85)80176-4
4. Beyer J, Petersen K, Song Y, Ruus A, Grung M, Bakke T, Tollefsen KE (2014) Environmental risk assessment of combined effects in aquatic ecotoxicology: a discussion paper. Mar Environ Res 96:81–91. doi:10.1016/j.marenvres.2013.10.008
5. Camacho-Muñoz MD, Santos JL, Aparicio I, Alonso E (2010) Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds. J Hazard Mater 177:1159–1162. doi:10.1016/j.jhazmat.2010.01.030
6. Cedergreen N, Kudsk P, Mathiassen SK, Sørensen H, Streibig JC (2007a) Reproducibility of binary-mixture toxicity studies. Environ Toxicol Chem 26:149–156. doi:10.1897/06-196R.1
7. Cedergreen N, Abbaspoor M, Sørensen H, Streibig JC (2007b) Is mixture toxicity measured on a biomarker indicative of what happens on a population level? A study with Lemna minor. Ecotox Environ Saf 67:323–332. doi:10.1016/j.ecoenv.2006.12.006
8. Cleuvers M (2003) Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142:185–194. doi:10.1016/S0378-4274(03)00068-7
9. Cleuvers M (2004) Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen and acetylsalicylic acid. Ecotoxicol Environ Saf 59:309–315. doi:10.1016/S0147-6513(03)00141-6
10. Cleuvers M (2005) Initial risk assessment for three beta-blockers found in the aquatic environment. Chemosphere 59:199–205. doi:10.1016/j.chemosphere.2004.11.090
11. European Commission (2003) Technical guidance document on risk assessment in support of Commission Directive 93/67/EEC on risk assessment for new notified substances, Commission Regulation (EC) No 1488/94 on risk assessment for existing substances, Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. Part II. Joint research Centre, Ispra
12. EPISuite-Estimation Program Interface (2012) Environmental Protection Agency. Office of Pollution Prevention and Toxics, Washington
13. European Commission (2015) Medicines and the environment—study on the risks of environmental effects of medicinal products. http://ec.europa.eu/health/human-use/environment-medicines/index_en.htm. Accessed 12 Jan 2015
14. Faust M, Altenburger R, Backhaus T, Blanck H, Boedeker W, Gramatica P, Hamer V, Scholze M, Vighi M, Grimme LH (2003) Joint algal toxicity of 16 dissimilarly acting chemicals is predictable by the concept of independent action. Aquat Toxicol 63:43–63. doi:10.1016/S0166-445X(02)00133-9
15. FDA. U.S. Food and Drug Administration (2002). Center for drug evaluation and research. Environmental assessment/FONSI. Approval package for application number 20-386/S-019 and 029. Review of Environment Assessment NDA 20-386 Cozaar Tablets (LOSARTAN POTASSIUM). http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/20-386S032_Cozaar_EAfonsi.pdf. Accessed 16 April 2014
16. Ferrari B, Mons R, Vollat B, Fraysse B, Paxéus N, Giudice RL, Pollio A, Garric J (2004) Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23:1344–1354. doi:10.1897/03-246
17. Franzellitti S, Buratti S, Valbonesi P, Capuzzo A, Fabbri E (2011) The β-blocker propranolol affects cAMP-dependent signaling and induces the stress response in Mediterranean mussels, Mytilus galloprovincialis. Aquat Toxicol 101:299–308. doi:10.1016/j.aquatox.2010.11.001
18. Fraysse B, Garric J (2005) Prediction and experimental validation of acute toxicity of beta-blockers in Ceriodaphnia dubia. Environ Toxicol Chem 24:2470–2476. doi:10.1897/04-541R.1
19. Frias MC (2013) Uso de genéricos contra hipertensão cresce 190 %. Folha de São Paulo. http://www1.folha.uol.com.br/colunas/mercadoaberto/2013/08/1323813-uso-de-genericos-contra-hipertensao-cresce-190.shtml. Accessed 20 May 2014
20. Ginebreda A, Muñoz I, López de Alda M, Brix R, López-Doval J, Barceló D (2010) Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes in the Llobregat River (NE Spain). Environ Int 36:153–162. doi:10.1016/j.envint.2009.10.003
21. Gómez MJ, Petrović M, Fernández-Alba AR, Barceló D (2006) Determination of pharmaceuticals of various therapeutic classes bysolid-phase extraction and liquid chromatography–tandem mass spectrometry analysis in hospital effluent wastewaters. J Chromatogr A 1114:224–233. doi:10.1016/j.chroma.2006.02.038
22. Greco WR, Bravo G, Parsons JC (1995) The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 47:331–385
23. Gros M, Rodríguez-Mozaz S, Barceló D (2012) Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J Chromatogr A 1248:104–121. doi:10.1016/j.chroma.2012.05.084
24. Gu Q, Burt VL, Dillon CF, Yoon S (2012) Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 126(17):2105–2114. doi:10.1161/CIRCULATIONAHA.112.096156
25. Hillman WS (1961) The lemnaceae or duckweeds: a review of the descriptive and experimental literature. Bot Rev 27:221–287. doi:10.1007/BF02860083
26. Huggett DB, Brooks BW, Peterson B, Foran CM, Schlenk D (2002) Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (β-blockers) on aquatic organisms. Arch Environ Contam Toxicol 43:229–235. doi:10.1007/s00244-002-1182-7
27. Huggett DB, Khan IA, Foran CM, Schlenk D (2003) Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. Environ Pollut 121:199–205. doi:10.1016/S0269-7491(02)00226-9
28. Isidori M, Lavorgna M, Nardelli A, Pascarella L, Parrella A (2005) Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci Total Environ 346:87–98. doi:10.1016/j.scitotenv.2004.11.017
29. Jones OAH, Voulvoulis N, Lester JN (2006) Partitioning behavior of five pharmaceutical compounds to activated sludge and river sediment. Arch Environ Contam Toxicol 50:297–305. doi:10.1007/s00244-005-1095-3
30. Jonker MJ, Svendsen C, Bedaux JJM, Bongers M, Kammenga JE (2005) Significance testing of synergistic/antagonistic, dose level-dependent or dose ratio-dependent effects in mixture dose-response analysis. Environ Toxicol Chem 24(10):2701–2713. doi:10.1897/04-431R.1
31. Kasprzyk-Hordern B (2010) Pharmacologically active compounds in the environment and their chirality. Chem Soc Rev 39:4466–4503. doi:10.1039/c000408c
32. Kaza M, Nalecz-Jawecki G, Sawicki J (2007) The toxicity of selected pharmaceuticals to the aquatic plant Lemna minor. Fresen Environ Bull 16:524–531
33. Larsson DGJ, de Pedro C, Paxeus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148:751–755. doi:10.1016/j.jhazmat.2007.07.008
34. Lepper P (2005) Manual on the methodological framework to derive environmental quality standards for priority substances in accordance with article 16 of the water framework directive (2000/60/EC). Fraunhofer-Institute Molecular Biology and Applied Ecology, Schmallenberg, Germany. http://www.helpdeskwater.nl/publish/pages/24007/_16__manual_on_the_methodological_framework_to_derive_environmental_quality_standards_for_priority_substances.pdf. Accessed 10 December 2013
35. Lewis MA (1995) Algae and vascular plant tests. In: Rand GM (ed) Fundamentals of aquatic toxicology-effects, environmental fate and risk assessment, 2nd edn. CRC Press, Washington, pp 135–169
36. Lin AYC, Tsai YT (2009) Occurrence of pharmaceuticals in Taiwan’s surface waters: impact of waste streams from hospitals and pharmaceutical production facilities. Sci Total Environ 407:3793–3802. doi:10.1016/j.scitotenv.2009.03.009
37. Lv M, Sun Q, Hu A, Hou L, Li J, Cai X, Yu CP (2014) Pharmaceuticals and personal care products in a mesoscale subtropical watershed and their application as sewage markers. J Hazard Mater 280:696–705. doi:10.1016/j.jhazmat.2014.08.054
38. Margot J, Kienle C, Magnet A, Weil M, Rossi L, de Alencastro LF, Abegglen C, Thonney D, Chèvre N, Schärer M, Barry DA (2013) Treatment of micropollutants in municipal wastewater: ozone or powdered activated carbon? Sci Total Environ 461–462:480–498. doi:10.1016/j.scitotenv.2013.05.034
39. Martin HL, Svendsen C, Lister LJ, Gomez-Eyles JL, Spurgeon DJ (2009) Measurement and modeling of the toxicity of binary mixtures in the nematode Caenorhabditis elegans—a test of independent action. Environ Toxicol Chem 28:97–104. doi:10.1897/07-215.1
40. Martins N, Pereira R, Abrantes N, Pereira J, Gonçalves F, Marques CR (2012) Ecotoxicological effects of ciprofloxacin on freshwater species: data integration and derivation of toxicity thresholds for risk assessment. Ecotoxicology 21:1167–1176. doi:10.1007/s10646-012-0871-x
41. Maszkowska J, Stolte S, Kumirska J, Lukaszewicz P, Mioduszewska K, Puckowski A, Caban M, Wagil M, Stepnowski P, Bialk-Bielińska A (2014a) Beta-blockers in the environment: part I. Mobility and hydrolysis study. Sci Total Environ 493:1112–1121. doi:10.1016/j.scitotenv.2014.06.023
42. Maszkowska J, Stolte S, Kumirska J, Lukaszewicz P, Mioduszewska K, Puckowski A, Caban M, Wagil M, Stepnowski P, Bialk-Bielińska A (2014b) Beta-blockers in the environment: part II. Ecotoxicity study. Sci Total Environ 493:1122–1126. doi:10.1016/j.scitotenv.2014.06.039
43. OECD (2001) Harmonized integrated classification system for human health and environmental hazards of chemical substances and mixtures. OECD series on testing and assessment No 33. Environment Directorate, Joint meeting of the chemicals committee and the working party on chemicals, pesticides and biotechnology. Organisation for Economic Co-operation and Development, Paris, France
44. OECD (2006) Lemna sp. Growth inhibition test. In: Guidelines for the Testing of chemicals. Updated Test Guideline 221. Organisation for Economic Co-operation and Development, Paris, France
45. Petersen K, Heiaas HH, Tollefsen KE (2014) Combined effects of pharmaceuticals, personal care products, biocides and organic contaminants on the growth of Skeletonema pseudocostatum. Aquat Toxicol 150:45–54. doi:10.1016/j.aquatox.2014.02.013
46. Petrović M, Škrbić B, Živančev J, Ferrando-Climent L, Barceló D (2014) Determination of 81 pharmaceutical drugs by high performance liquid chromatography coupled to mass spectrometry with hybrid triple quadrupole–linear ion trap in different types of water in Serbia. Sci Total Environ 468–469:415–428. doi:10.1016/j.scitotenv.2013.08.079
47. Portal Fator Brasil (2013) Consumo de medicamentos genéricos para hipertensão cresce 190 % em menos de 2 anos. http://www.revistafatorbrasil.com.br/ver_noticia.php?not=243422. Accessed 17 May 2014
48. Qin LT, Liu SS, Zhang J, Xiao QF (2011) A novel model integrated concentration addition with independent action for the prediction of toxicity of multi-component mixture. Toxicology 280:164–172. doi:10.1016/j.tox.2010.12.007
49. Roberts PH, Thomas KV (2006) The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci Total Environ 356:143–153. doi:10.1016/j.scitotenv.2005.04.031
50. Santos LHMLM, Araújo AN, Fachini A, Pena A, Delerue-Matos C, Montenegro MCBSM (2010) Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J Hazard Mater 175:45–95. doi:10.1016/j.jhazmat.2009.10.100
51. Schuster J (2014) Focus on plant problems—Chlorosis. University of Illinois Extension. http://urbanext.illinois.edu/focus/index.cfm?problem=chlorosis. Accessed 12 May 2014
52. Spurgeon DJ, Jones OA, Dorne JL, Svendsen C, Swain S, Stürzenbaum SR (2010) Systems toxicology approaches for understanding the joint effects of environmental chemical mixtures. Sci Total Environ 408:3725–3734. doi:10.1016/j.scitotenv.2010.02.038
53. Stanley JK, Ramirez AJ, Mottaleb M, Chambliss CK, Brooks BW (2006) Enantiospecific toxicity of the beta-blocker propranolol to Daphnia magna and Pimephales promelas. Environ Toxicol Chem 25:1780–1786. doi:10.1897/05-298R1.1
54. Taylor D, Senac T (2014) Human pharmaceutical products in the environment–the “problem” in perspective. Chemosphere 115:95–99. doi:10.1016/j.chemosphere.2014.01.011
55. Ternes TA (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245–3260. doi:10.1016/S0043-1354(98)00099-2
56. Umbuzeiro GA, de Simone S, de Deus ACCR, Altafin L, Veiga LF, Alves LSN, de Castro MLMP, Lamparelli MC, von der Ohe PC, Araújo RPA, Vargas VMF (2011) Protocol for water quality criteria derivation for the protection of Aquatic Life in Brazil—water quality criteria (WQC). http://www.sbmcta.org.br/_img/_documentos/6fcdb2951819a022c6c46c51f89df49a.pdf. Accessed 14 June 2014
57. Wang LJ, Liu SS, Zhang J, Li WY (2010) A new effect residual ratio (ERR) method for the validation of the concentration addition and independent action models. Environ Sci Pollut Res Int 17:1080–1089. doi:10.1007/s11356-009-0265-7
58. Yamamoto NS, Pereira CDS, Cortez FS, Pusceddu FH, Santos AR, Guimarães LL (2012) Avaliação dos efeitos biológicos do fármaco Losartan em microcrustáceos Daphnia similis e Ceriodaphnia dubia (CRUSTACEA, CLADOCERA). Unisanta BioSci 1:49–53
59. Yamamoto NS, Pereira CDS, Cortez FS, Pusceddu FH, Santos AR, Toma W, Guimarães LL (2014) Avaliação dos efeitos biológicos adversos dos fármacos anti-hipertensivos Losartan e Valsartan em ouriço-do-mar Lytechinus variegatus (ECHINODERMATA, ECHINOIDEA). Unisanta BioSci 3:27–32
60. Yang Y, Fu J, Peng H, Hou L, Liu M, Zhou JL (2011) Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone. J Hazard Mater 190:588–596. doi:10.1016/j.jhazmat.2011.03.092